Credit Suisse Ag Selecta Biosciences Inc Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.23 - $3.31 $14,349 - $38,614	-11,666 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.89 - $4.43 $33,714 - $51,680	11,666 New	11,666 $37,000
Q1 2021 May 14, 2021	SELL	$2.92 - $5.07 $60,035 - $104,239	-20,560 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$1.64 - $3.42 $33,718 - $70,315	20,560 New	20,560 $62,000
Q4 2017 Feb 14, 2018	SELL	$8.97 - $23.38 $101,172 - $263,703	-11,279 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$15.22 - $20.03 $171,666 - $225,918	11,279	11,279 $205,000

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.